Allergan, Richter's bipolar depression drug succeeds in key trial

Medications
1

https://www.reuters.com/article/us-allergan-study/allergan-richter-depression-drug-succeeds-key-trial-idUSKBN1EC1NA

The drug, cariprazine, sold under the brand name Vraylar, is already approved to treat manic or mixed episodes of bipolar disorder and schizophrenia in adults.

3 Likes